Fmr LLC Trims Holdings in Humana Inc. (NYSE:HUM)

Fmr LLC lowered its stake in shares of Humana Inc. (NYSE:HUM) by 4.0% in the fourth quarter, HoldingsChannel.com reports. The firm owned 3,254,141 shares of the insurance provider’s stock after selling 134,718 shares during the period. Fmr LLC’s holdings in Humana were worth $825,608,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Pinnacle Wealth Management Advisory Group LLC boosted its position in shares of Humana by 3.6% during the fourth quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,070 shares of the insurance provider’s stock worth $272,000 after buying an additional 37 shares during the period. Atlas Brown Inc. boosted its holdings in Humana by 0.6% during the 4th quarter. Atlas Brown Inc. now owns 6,352 shares of the insurance provider’s stock valued at $1,611,000 after acquiring an additional 38 shares during the period. Mather Group LLC. grew its position in Humana by 21.0% in the 4th quarter. Mather Group LLC. now owns 236 shares of the insurance provider’s stock valued at $60,000 after acquiring an additional 41 shares in the last quarter. Capital Advisors Ltd. LLC increased its stake in Humana by 26.1% during the fourth quarter. Capital Advisors Ltd. LLC now owns 208 shares of the insurance provider’s stock worth $53,000 after purchasing an additional 43 shares during the period. Finally, Retirement Planning Co of New England Inc. lifted its position in shares of Humana by 4.7% during the fourth quarter. Retirement Planning Co of New England Inc. now owns 966 shares of the insurance provider’s stock worth $245,000 after purchasing an additional 43 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently weighed in on HUM. Piper Sandler upped their target price on shares of Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 15th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $290.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Barclays lifted their target price on Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a report on Thursday, February 13th. StockNews.com upgraded Humana from a “hold” rating to a “buy” rating in a report on Monday. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $283.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Seventeen analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $280.17.

Humana Price Performance

Humana stock opened at $255.42 on Tuesday. The firm’s 50-day moving average is $266.73 and its two-hundred day moving average is $271.15. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. The stock has a market capitalization of $30.83 billion, a P/E ratio of 25.67, a P/E/G ratio of 2.05 and a beta of 0.62. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $406.46.

Humana (NYSE:HUM) last posted its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Equities analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 annualized dividend and a dividend yield of 1.39%. Humana’s payout ratio is 35.58%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.